C12Y 304/24065
Macrophage elastase , i.e. metalloelastase
Official title: Macrophage elastase (3.4.24.65), i.e. metalloelastase
C12Y304/24065 (Macrophage elastase , i.e. metalloelastase) appears on 26 US grants and 32 published applications in this corpus.
Search patents in C12Y- Granted patents
- 26
- Published applications
- 32
- Assignees
- 9
- Inventors
- 22
- Latest grant
- 24 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 3 | 3 |
| 2017 | 0 | 4 |
| 2018 | 3 | 0 |
| 2019 | 5 | 6 |
| 2020 | 1 | 5 |
| 2021 | 4 | 2 |
| 2022 | 0 | 4 |
| 2023 | 2 | 3 |
| 2024 | 4 | 1 |
| 2025 | 1 | 1 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Matrix metalloproteinase (MMP) inhibitors and methods of use thereof24 Mar 2026US 12,583,844 B2Foresee Pharmaceuticals USA, Inc.
- Matrix metalloproteinase (MMP) inhibitors and methods of use thereof23 Dec 2025US 12,503,460 B2Foresee Pharmaceuticals USA, Inc.
- Immunotherapy against several tumors including lung cancer26 Mar 2024US 11,939,400 B2Immatics Biotechnologies GmbH
- Immunotherapy against several tumors including lung cancer26 Mar 2024US 11,939,401 B2Immatics Biotechnologies GmbH
- Immunotherapy against several tumors including lung cancer9 Jan 2024US 11,866,517 B2Immatics Biotechnologies GmbH
- Immunotherapy against several tumors including lung cancer27 Feb 2025US 2025/0066422 A1Immatics Biotechnologies GmbH
- Immunotherapy against several tumors including lung cancer6 Jun 2024US 2024/0182522 A1Immatics Biotechnologies GmbH
- Matrix metalloproteinase (mmp) inhibitors and methods of use thereof16 Nov 2023US 2023/0365543 A1Foresee Pharmaceuticals Co., Ltd.
- Modified serine protease proproteins2 Nov 2023US 2023/0348881 A1Onchilles Pharma, Inc.
- Matrix metalloproteinase (mmp) inhibitors and methods of use thereof19 Jan 2023US 2023/0014855 A1Foresee Pharmaceuticals Co., Ltd.
Most cited
By later US patents
- Immunotherapy against several tumors, such as lung cancer, including NSCLC198US 10,071,148 B2Immatics Biotechnologies GmbH · 2018
- Immunotherapy against several tumors, such as lung cancer, including NSCLC131US 9,943,579 B2Immatics Biotechnologies GmbH · 2018
- Systems, compositions, and methods for transplantation and treating conditions14US 9,352,021 B2Cytonics Corporation · 2016
- Immunotherapy against several tumors, such as lung cancer, including NSCLC12US 10,160,786 B1Immatics Biotechnologies GmbH · 2018
- Immunotherapy against several tumors, such as lung cancer, including NSCLC11US 10,316,063 B1Immatics Biotechnologies GmbH · 2019